The Behavioral and Field Research Core (BFRC) is designed to facilitate the integration of communication and behavioral research across the Cancer Center by translating research findings from the behavioral sciences into work in epidemiology, cancer prevention, clinical and developmental therapeutics, palliative care, and genetics. Resources available through BFRC include real-time video recording and coding of clinical interactions, access to an extensive video archive for communication and behavioral studies geographical and population tracking/mapping capabilities, community research participant registries at KCI access to comprehensive national datasets (e.g., HINTS, Health and Retirement Survey), as well as an extensive bank of clinical and social/behavioral instruments and measures. The Core offers expertise in communication science and behavioral research methodologies, design and evaluation of evidence-based social and behavioral interventions (including social marketing as a systematic approach to population level behavior change), social network methodology and analysis, quality of life measurement utilizing the most appropriate instruments, ecological momentary assessment, and electronic daily diaries (QOL has emerged as a critical factor in developmental therapeutic trials), and community based participatory research, particularty related to health disparities. The Core maintains an active network of community organization partnerships across the Institute's catchment area. Community partners participate in Research Advisory Committees and Community Advisory Committees, providing community perspective, input and facilitating access to the populations they serve. Through these partnerships the Core facilitates community access for Institute researchers, thus serving to assist in the translation and dissemination of behavioral research.
Expertise, technological skills and equipment within the BFRC allow investigators interested in behavioral and communication research to move quickly into data capture, codebook development, coding and analysis, particulariy of real time observational data. Investigators can readily conduct community based participatory research because the BFRC has built a trusted presence through the network of community partners. Currently, the BFRC is the only facility of its kind available to cancer center members and the WSU community.
|Ratanatharathorn, V; Deol, A; Ayash, L et al. (2015) Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT. Bone Marrow Transplant 50:106-12|
|Bollig-Fischer, Aliccia; Chen, Wei; Gadgeel, Shirish M et al. (2015) Racial diversity of actionable mutations in non-small cell lung cancer. J Thorac Oncol 10:250-5|
|Motzer, Robert J; Rini, Brian I; McDermott, David F et al. (2015) Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial. J Clin Oncol 33:1430-7|
|Wijesinghe, Priyanga; Bepler, Gerold; Bollig-Fischer, Aliccia (2015) A mass spectrometry assay to simultaneously analyze ROS1 and RET fusion gene expression in non-small-cell lung cancer. J Thorac Oncol 10:381-6|
|Koo, Imhoi; Wei, Xiaoli; Shi, Xue et al. (2014) Constructing Metabolic Association Networks Using High-dimensional Mass Spectrometry Data. Chemometr Intell Lab Syst 138:193-202|
|Koo, Imhoi; Yao, Sen; Zhang, Xiang et al. (2014) Comparative analysis of false discovery rate methods in constructing metabolic association networks. J Bioinform Comput Biol 12:1450018|
|Szalai, Gabor; Xu, Yi; Romero, Roberto et al. (2014) In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy. PLoS One 9:e110867|
|Heng, D Y C; Choueiri, T K; Rini, B I et al. (2014) Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. Ann Oncol 25:149-54|
|Speyer, Cecilia L; Hachem, Ali H; Assi, Ali A et al. (2014) Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer. PLoS One 9:e88830|
|Bengsch, F; Buck, A; Gunther, S C et al. (2014) Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene 33:4474-84|
Showing the most recent 10 out of 321 publications